Click here for more articles b. A growing controversy over alleged illegal medical services has put comedian Park Na-rae and ...

Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...

BY day, Thomas Delaney appeared a thoroughly grounded guy, holding down a busy job as a business development executive. But ...

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

The reality is that there is currently no FDA-approved testosterone product for women — and the only concrete evidence that testosterone might improve low libido applies to postmenopausal women. Even ...

A new analysis of clinical trial data indicates that psilocybin, when administered alongside psychotherapy, may provide rapid ...

“I was very reluctant to take any medication at first. I was like: ‘No, I’m not that bad. I don’t want to do anything bad to ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...